Dr. Christopher P. Wild

Christopher Paul Wild obtained his PhD in 1984 from the University of Manchester, UK, whilst working on DNA damage and repair. He was awarded a post-doctoral fellowship from the International Agency for Research on Cancer (IARC) to work in Lyon, France, and subsequently a UK Royal Society European Exchange Fellowship to spend a year at the Netherlands Cancer Institute in Amsterdam.  In 1987 Dr Wild re-joined IARC as a staff scientist and later became Chief of the Unit of Environmental Carcinogenesis. He was appointed to the Chair of Molecular Epidemiology at the University of Leeds in 1996, was Head of the Centre for Epidemiology and Biostatistics and later became Director of the Leeds Institute of Genetics, Health and Therapeutics in December 2005. Dr Wild was elected Director of IARC from 1st January 2009 and was appointed for a second term of office as from January 2014.   His main research interest is to understand the interplay between environmental and genetic risk factors in the causation of human cancer. In this context he proposed the concept of the “exposome” to draw attention to the need to improve exposure assessment for application in epidemiological studies of disease aetiology. His specific areas of research have been on liver and oesophageal cancers.  As IARC Director, Dr Wild has focused the organization on providing the evidence-base for cancer prevention including: describing the global burden of cancer; understanding the causes; and evaluating preventive interventions and their implementation

Comments are closed